These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25319266)

  • 1. Questioning the prevalence and reliability of human mitochondrial DNA heteroplasmy from massively parallel sequencing data.
    Just RS; Irwin JA; Parson W
    Proc Natl Acad Sci U S A; 2014 Oct; 111(43):E4546-7. PubMed ID: 25319266
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to Just et al.: Mitochondrial DNA heteroplasmy could be reliably detected with massively parallel sequencing technologies.
    Ye K; Lu J; Ma F; Keinan A; Gu Z
    Proc Natl Acad Sci U S A; 2014 Oct; 111(43):E4548-50. PubMed ID: 25319265
    [No Abstract]   [Full Text] [Related]  

  • 3. Comprehensive Mitochondrial Genome Analysis by Massively Parallel Sequencing.
    Palculict ME; Zhang VW; Wong LJ; Wang J
    Methods Mol Biol; 2016; 1351():3-17. PubMed ID: 26530670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Manipulation of mtDNA Heteroplasmy: A Shifting Perspective.
    Jackson CB; Turnbull DM; Minczuk M; Gammage PA
    Trends Mol Med; 2020 Jul; 26(7):698-709. PubMed ID: 32589937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extensive pathogenicity of mitochondrial heteroplasmy in healthy human individuals.
    Ye K; Lu J; Ma F; Keinan A; Gu Z
    Proc Natl Acad Sci U S A; 2014 Jul; 111(29):10654-9. PubMed ID: 25002485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High throughput single cell analysis of mitochondrial heteroplasmy in mitochondrial diseases.
    Maeda R; Kami D; Maeda H; Shikuma A; Gojo S
    Sci Rep; 2020 Jul; 10(1):10821. PubMed ID: 32616755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manipulation of Murine Mitochondrial DNA Heteroplasmy with mtZFNs.
    Nash PA; Minczuk M
    Methods Mol Biol; 2023; 2615():329-344. PubMed ID: 36807802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New potentials of mitochondrial DNA editing.
    Wang W; Wang X
    Cell Biol Toxicol; 2020 Oct; 36(5):391-393. PubMed ID: 32734362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial DNA heteroplasmy in the emerging field of massively parallel sequencing.
    Just RS; Irwin JA; Parson W
    Forensic Sci Int Genet; 2015 Sep; 18():131-9. PubMed ID: 26009256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial replacement to prevent the transmission of mitochondrial DNA disease.
    Herbert M; Turnbull D
    EMBO Rep; 2015 May; 16(5):539-40. PubMed ID: 25888328
    [No Abstract]   [Full Text] [Related]  

  • 11. Techniques and pitfalls in the detection of pathogenic mitochondrial DNA mutations.
    Moraes CT; Atencio DP; Oca-Cossio J; Diaz F
    J Mol Diagn; 2003 Nov; 5(4):197-208. PubMed ID: 14573777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Problems in Mitochondrial DNA forensics: while interpreting length heteroplasmy conundrum of various Sindhi and Baluchi ethnic groups of Pakistan.
    Bhatti S; Aslam Khan M; Abbas S; Attimonelli M; Gonzalez GR; Aydin HH; de Souza EMS
    Mitochondrial DNA A DNA Mapp Seq Anal; 2018 May; 29(4):501-510. PubMed ID: 28391756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of measuring heteroplasmy of a pathogenic mitochondrial DNA variant at the single-cell level in individuals with mitochondrial disease.
    Imai-Okazaki A; Nitta KR; Yatsuka Y; Sugiura A; Arao M; Shimura M; Ebihara T; Onuki T; Ichimoto K; Ohtake A; Murayama K; Okazaki Y
    J Inherit Metab Dis; 2022 Nov; 45(6):1143-1150. PubMed ID: 36053827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENs.
    Bacman SR; Williams SL; Pinto M; Peralta S; Moraes CT
    Nat Med; 2013 Sep; 19(9):1111-3. PubMed ID: 23913125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial manipulations.
    Nat Med; 2014 May; 20(5):451-2. PubMed ID: 24804738
    [No Abstract]   [Full Text] [Related]  

  • 16. Mitochondrial DNA heteroplasmy in disease and targeted nuclease-based therapeutic approaches.
    Nissanka N; Moraes CT
    EMBO Rep; 2020 Mar; 21(3):e49612. PubMed ID: 32073748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial DNA mutation m.3243A>G is associated with altered mitochondrial function in peripheral blood mononuclear cells, with heteroplasmy levels and with clinical phenotypes.
    Geng X; Zhang Y; Yan J; Chu C; Gao F; Jiang Z; Zhang X; Chen Y; Wei X; Feng Y; Lu H; Wang C; Zeng F; Jia W
    Diabet Med; 2019 Jun; 36(6):776-783. PubMed ID: 30536471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assaying the probabilities of obtaining maternally inherited heteroplasmy as the basis for modeling OXPHOS diseases in animals.
    Bass MG; Sokolova VA; Kustova ME; Grachyova EV; Kidgotko OV; Sorokin AV; Vasilyev VB
    Biochim Biophys Acta; 2006; 1757(5-6):679-85. PubMed ID: 16829232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial disorders come full circle.
    Chinnery PF
    Neurology; 2003 Oct; 61(7):878-80. PubMed ID: 14557551
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of chemically modified oligonucleotides targeting a pathogenic mutation in human mitochondrial DNA.
    Tonin Y; Heckel AM; Dovydenko I; Meschaninova M; Comte C; Venyaminova A; Pyshnyi D; Tarassov I; Entelis N
    Biochimie; 2014 May; 100():192-9. PubMed ID: 23994754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.